SCHEMBL14799282

SCHEMBL14799282

CCOC(=O)c1ccc(OC)c(NS(C)(=O)=O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.59
RECQL P46063 1/20 0.59
HSD17B2 P37059 1/20 0.56
LMNA P02545 2/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
KDM4E B2RXH2 3/20 0.55
HSD17B10 Q99714 2/20 0.55
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
CYP2C9 P11712 2/20 0.53
MAPT P10636 4/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
GAA P10253 2/20 0.51
THRB P10828 1/20 0.49
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.49
ALDH1A1 P00352 3/20 0.49
CDC25B P30305 1/20 0.48
CA1 P00915 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5071184 0.87 SMN1; SMN2 (0.70) HPGDLMNASMN1; SMN2KDM4EHSD17B10
SCHEMBL14799014 0.84 SMN1; SMN2 (0.53) HPGDLMNASMN1; SMN2KDM4EHSD17B10
SCHEMBL8959046 0.83 HPGD (0.67) HPGDRECQLLMNASMN1; SMN2KDM4E
SCHEMBL8959050 0.83 HPGD (0.62) HPGDRECQLHSD17B2LMNASMN1; SMN2
SCHEMBL14447114 0.82 HSD17B2 (0.57) HPGDHSD17B2LMNASMN1; SMN2KDM4E
SCHEMBL5494824 0.81 ACLY (0.58) LMNASMN1; SMN2KDM4EHSD17B10RAB9A
SCHEMBL7039348 0.80 ALDH1A1 (0.50) LMNASMN1; SMN2KDM4EHSD17B10CYP2C9
SCHEMBL8887638 0.80 PTGER4 (0.64) HPGDRECQLLMNASMN1; SMN2KDM4E
SCHEMBL14798705 0.79 THRB (0.50) HPGDLMNASMN1; SMN2KDM4ECYP2C9
SCHEMBL8888568 0.79 HPGD (0.53) HPGDRECQLLMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760838-B1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARM SPA (IT) 2017-05-10 EP disclosed
US-9265768-B2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2016-02-23 US disclosed
EP-2760838-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2014-08-06 EP disclosed
US-20140142074-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-05-22 US disclosed
WO-2013045280-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-04-04 WO disclosed
US-20130079313-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079313-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A HPGD 145/4885RECQL 1834/4885HSD17B2 348/4885
US-20140142074-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A HPGD 145/4885RECQL 1834/4885HSD17B2 348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.